ABOUT US
CONTACT US
FAQ
PRIVACY POLICY
REFUND AND CANCELLATION
BLOGS
COMPANIES
REPORTS
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Subcutaneous Drug Delivery Equipment Market Research Report 2025
Published Date: August 2025
|
Report Code: QYRE-Auto-11K9563
Home | Market Reports | Business & Industrial| Pharmaceuticals & Biotech
Global Subcutaneous Drug Delivery Equipment Market Insights and Forecast to 2028
BUY CHAPTERS

Global Subcutaneous Drug Delivery Equipment Market Research Report 2025

Code: QYRE-Auto-11K9563
Report
August 2025
Pages:97
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES
FEATURED COMPANIES
Boehringer Ingelheim
Eli Lily
Galaxo
HMD pharmaceuticals
Merck
Novartis
Novo Nordisk
Pfizer Inc
Sanofi
Teva Pharmaceutical
Zogenix

Subcutaneous Drug Delivery Equipment Market Size

According to our research, the global market for medical devices is estimated at US$ 603 billion in the year 2023, and will be growing at a CAGR of 5% during next six years.

Subcutaneous Drug Delivery Equipment Market

Subcutaneous Drug Delivery Equipment Market

The global market for Subcutaneous Drug Delivery Equipment was valued at US$ million in the year 2024 and is projected to reach a revised size of US$ million by 2031, growing at a CAGR of %during the forecast period.
The global healthcare spending contributes to occupy 10% of the global GDP and is continuously rising in recent years due to the increasing health needs of the aging population, the growing prevalence of chronic and infectious diseases and the expansion of emerging markets. The medical devices market plays a significant role in the healthcare industry. The market is driven by several factors, including the increasing demand for advanced healthcare services globally, advancements in medical technology, growing geriatric population, rising healthcare expenditure, and increasing awareness about early disease diagnosis and treatment.

Report Scope

This report aims to provide a comprehensive presentation of the global market for Subcutaneous Drug Delivery Equipment, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Subcutaneous Drug Delivery Equipment.
The Subcutaneous Drug Delivery Equipment market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Subcutaneous Drug Delivery Equipment market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Subcutaneous Drug Delivery Equipment manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Scope of Subcutaneous Drug Delivery Equipment Market Report

Report Metric Details
Report Name Subcutaneous Drug Delivery Equipment Market
Accounted market size in year US$ 603 billion
CAGR 5%
Base Year year
Segment by Type
Segment by Application
  • In-Patient
  • Out-Patient
  • Clinic
  • Others
Consumption by Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia)
  • Asia-Pacific (China, Japan, South Korea, Taiwan)
  • Southeast Asia (India)
  • Latin America (Mexico, Brazil)
By Company Boehringer Ingelheim, Eli Lily, Galaxo, HMD pharmaceuticals, Merck, Novartis, Novo Nordisk, Pfizer, Sanofi, Teva Pharmaceutical, Zogenix
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Core Chapters

  • Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
  • Chapter 2: Detailed analysis of Subcutaneous Drug Delivery Equipment manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
  • Chapter 3: Sales, revenue of Subcutaneous Drug Delivery Equipment in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
  • Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
  • Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
  • Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
  • Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
  • Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
  • Chapter 9: The main points and conclusions of the report. 

FAQ for this report

Who are the main players in the Subcutaneous Drug Delivery Equipment Market report?

Ans: The main players in the Subcutaneous Drug Delivery Equipment Market are Boehringer Ingelheim, Eli Lily, Galaxo, HMD pharmaceuticals, Merck, Novartis, Novo Nordisk, Pfizer, Sanofi, Teva Pharmaceutical, Zogenix

What are the Application segmentation covered in the Subcutaneous Drug Delivery Equipment Market report?

Ans: The Applications covered in the Subcutaneous Drug Delivery Equipment Market report are In-Patient, Out-Patient, Clinic, Others

What are the Type segmentation covered in the Subcutaneous Drug Delivery Equipment Market report?

Ans: The Types covered in the Subcutaneous Drug Delivery Equipment Market report are Syringe Based Subcutaneous Drug Delivery, Subcutaneous Implants, Pen Systems for Subcutaneous Drug Delivery, Auto Injectors, Pump Based Drug Delivery Systems

Recommended Reports

Drug Delivery Devices

Medical Equipment

Diagnosis and Monitoring

1 Subcutaneous Drug Delivery Equipment Market Overview
1.1 Product Definition
1.2 Subcutaneous Drug Delivery Equipment by Type
1.2.1 Global Subcutaneous Drug Delivery Equipment Market Value Comparison by Type (2024 VS 2031)
1.2.2 Syringe Based Subcutaneous Drug Delivery
1.2.3 Subcutaneous Implants
1.2.4 Pen Systems for Subcutaneous Drug Delivery
1.2.5 Auto Injectors
1.2.6 Pump Based Drug Delivery Systems
1.3 Subcutaneous Drug Delivery Equipment by Application
1.3.1 Global Subcutaneous Drug Delivery Equipment Market Value by Application (2024 VS 2031)
1.3.2 In-Patient
1.3.3 Out-Patient
1.3.4 Clinic
1.3.5 Others
1.4 Global Subcutaneous Drug Delivery Equipment Market Size Estimates and Forecasts
1.4.1 Global Subcutaneous Drug Delivery Equipment Revenue 2020-2031
1.4.2 Global Subcutaneous Drug Delivery Equipment Sales 2020-2031
1.4.3 Global Subcutaneous Drug Delivery Equipment Market Average Price (2020-2031)
1.5 Assumptions and Limitations
2 Subcutaneous Drug Delivery Equipment Market Competition by Manufacturers
2.1 Global Subcutaneous Drug Delivery Equipment Sales Market Share by Manufacturers (2020-2025)
2.2 Global Subcutaneous Drug Delivery Equipment Revenue Market Share by Manufacturers (2020-2025)
2.3 Global Subcutaneous Drug Delivery Equipment Average Price by Manufacturers (2020-2025)
2.4 Global Key Players of Subcutaneous Drug Delivery Equipment, Industry Ranking, 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Subcutaneous Drug Delivery Equipment, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Subcutaneous Drug Delivery Equipment, Product Type & Application
2.7 Global Key Manufacturers of Subcutaneous Drug Delivery Equipment, Date of Enter into This Industry
2.8 Global Subcutaneous Drug Delivery Equipment Market Competitive Situation and Trends
2.8.1 Global Subcutaneous Drug Delivery Equipment Market Concentration Rate
2.8.2 The Global 5 and 10 Largest Subcutaneous Drug Delivery Equipment Players Market Share by Revenue
2.8.3 Global Subcutaneous Drug Delivery Equipment Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
2.9 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Global Subcutaneous Drug Delivery Equipment Market Scenario by Region
3.1 Global Subcutaneous Drug Delivery Equipment Market Size by Region: 2020 Versus 2024 Versus 2031
3.2 Global Subcutaneous Drug Delivery Equipment Sales by Region: 2020-2031
3.2.1 Global Subcutaneous Drug Delivery Equipment Sales by Region: 2020-2025
3.2.2 Global Subcutaneous Drug Delivery Equipment Sales by Region: 2026-2031
3.3 Global Subcutaneous Drug Delivery Equipment Revenue by Region: 2020-2031
3.3.1 Global Subcutaneous Drug Delivery Equipment Revenue by Region: 2020-2025
3.3.2 Global Subcutaneous Drug Delivery Equipment Revenue by Region: 2026-2031
3.4 North America Subcutaneous Drug Delivery Equipment Market Facts & Figures by Country
3.4.1 North America Subcutaneous Drug Delivery Equipment Market Size by Country: 2020 VS 2024 VS 2031
3.4.2 North America Subcutaneous Drug Delivery Equipment Sales by Country (2020-2031)
3.4.3 North America Subcutaneous Drug Delivery Equipment Revenue by Country (2020-2031)
3.4.4 U.S.
3.4.5 Canada
3.5 Europe Subcutaneous Drug Delivery Equipment Market Facts & Figures by Country
3.5.1 Europe Subcutaneous Drug Delivery Equipment Market Size by Country: 2020 VS 2024 VS 2031
3.5.2 Europe Subcutaneous Drug Delivery Equipment Sales by Country (2020-2031)
3.5.3 Europe Subcutaneous Drug Delivery Equipment Revenue by Country (2020-2031)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Subcutaneous Drug Delivery Equipment Market Facts & Figures by Region
3.6.1 Asia Pacific Subcutaneous Drug Delivery Equipment Market Size by Region: 2020 VS 2024 VS 2031
3.6.2 Asia Pacific Subcutaneous Drug Delivery Equipment Sales by Region (2020-2031)
3.6.3 Asia Pacific Subcutaneous Drug Delivery Equipment Revenue by Region (2020-2031)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.6.13 Philippines
3.7 Latin America Subcutaneous Drug Delivery Equipment Market Facts & Figures by Country
3.7.1 Latin America Subcutaneous Drug Delivery Equipment Market Size by Country: 2020 VS 2024 VS 2031
3.7.2 Latin America Subcutaneous Drug Delivery Equipment Sales by Country (2020-2031)
3.7.3 Latin America Subcutaneous Drug Delivery Equipment Revenue by Country (2020-2031)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Subcutaneous Drug Delivery Equipment Market Facts & Figures by Country
3.8.1 Middle East and Africa Subcutaneous Drug Delivery Equipment Market Size by Country: 2020 VS 2024 VS 2031
3.8.2 Middle East and Africa Subcutaneous Drug Delivery Equipment Sales by Country (2020-2031)
3.8.3 Middle East and Africa Subcutaneous Drug Delivery Equipment Revenue by Country (2020-2031)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Subcutaneous Drug Delivery Equipment Sales by Type (2020-2031)
4.1.1 Global Subcutaneous Drug Delivery Equipment Sales by Type (2020-2025)
4.1.2 Global Subcutaneous Drug Delivery Equipment Sales by Type (2026-2031)
4.1.3 Global Subcutaneous Drug Delivery Equipment Sales Market Share by Type (2020-2031)
4.2 Global Subcutaneous Drug Delivery Equipment Revenue by Type (2020-2031)
4.2.1 Global Subcutaneous Drug Delivery Equipment Revenue by Type (2020-2025)
4.2.2 Global Subcutaneous Drug Delivery Equipment Revenue by Type (2026-2031)
4.2.3 Global Subcutaneous Drug Delivery Equipment Revenue Market Share by Type (2020-2031)
4.3 Global Subcutaneous Drug Delivery Equipment Price by Type (2020-2031)
5 Segment by Application
5.1 Global Subcutaneous Drug Delivery Equipment Sales by Application (2020-2031)
5.1.1 Global Subcutaneous Drug Delivery Equipment Sales by Application (2020-2025)
5.1.2 Global Subcutaneous Drug Delivery Equipment Sales by Application (2026-2031)
5.1.3 Global Subcutaneous Drug Delivery Equipment Sales Market Share by Application (2020-2031)
5.2 Global Subcutaneous Drug Delivery Equipment Revenue by Application (2020-2031)
5.2.1 Global Subcutaneous Drug Delivery Equipment Revenue by Application (2020-2025)
5.2.2 Global Subcutaneous Drug Delivery Equipment Revenue by Application (2026-2031)
5.2.3 Global Subcutaneous Drug Delivery Equipment Revenue Market Share by Application (2020-2031)
5.3 Global Subcutaneous Drug Delivery Equipment Price by Application (2020-2031)
6 Key Companies Profiled
6.1 Boehringer Ingelheim
6.1.1 Boehringer Ingelheim Company Information
6.1.2 Boehringer Ingelheim Description and Business Overview
6.1.3 Boehringer Ingelheim Subcutaneous Drug Delivery Equipment Sales, Revenue and Gross Margin (2020-2025)
6.1.4 Boehringer Ingelheim Subcutaneous Drug Delivery Equipment Product Portfolio
6.1.5 Boehringer Ingelheim Recent Developments/Updates
6.2 Eli Lily
6.2.1 Eli Lily Company Information
6.2.2 Eli Lily Description and Business Overview
6.2.3 Eli Lily Subcutaneous Drug Delivery Equipment Sales, Revenue and Gross Margin (2020-2025)
6.2.4 Eli Lily Subcutaneous Drug Delivery Equipment Product Portfolio
6.2.5 Eli Lily Recent Developments/Updates
6.3 Galaxo
6.3.1 Galaxo Company Information
6.3.2 Galaxo Description and Business Overview
6.3.3 Galaxo Subcutaneous Drug Delivery Equipment Sales, Revenue and Gross Margin (2020-2025)
6.3.4 Galaxo Subcutaneous Drug Delivery Equipment Product Portfolio
6.3.5 Galaxo Recent Developments/Updates
6.4 HMD pharmaceuticals
6.4.1 HMD pharmaceuticals Company Information
6.4.2 HMD pharmaceuticals Description and Business Overview
6.4.3 HMD pharmaceuticals Subcutaneous Drug Delivery Equipment Sales, Revenue and Gross Margin (2020-2025)
6.4.4 HMD pharmaceuticals Subcutaneous Drug Delivery Equipment Product Portfolio
6.4.5 HMD pharmaceuticals Recent Developments/Updates
6.5 Merck
6.5.1 Merck Company Information
6.5.2 Merck Description and Business Overview
6.5.3 Merck Subcutaneous Drug Delivery Equipment Sales, Revenue and Gross Margin (2020-2025)
6.5.4 Merck Subcutaneous Drug Delivery Equipment Product Portfolio
6.5.5 Merck Recent Developments/Updates
6.6 Novartis
6.6.1 Novartis Company Information
6.6.2 Novartis Description and Business Overview
6.6.3 Novartis Subcutaneous Drug Delivery Equipment Sales, Revenue and Gross Margin (2020-2025)
6.6.4 Novartis Subcutaneous Drug Delivery Equipment Product Portfolio
6.6.5 Novartis Recent Developments/Updates
6.7 Novo Nordisk
6.7.1 Novo Nordisk Company Information
6.7.2 Novo Nordisk Description and Business Overview
6.7.3 Novo Nordisk Subcutaneous Drug Delivery Equipment Sales, Revenue and Gross Margin (2020-2025)
6.7.4 Novo Nordisk Subcutaneous Drug Delivery Equipment Product Portfolio
6.7.5 Novo Nordisk Recent Developments/Updates
6.8 Pfizer
6.8.1 Pfizer Company Information
6.8.2 Pfizer Description and Business Overview
6.8.3 Pfizer Subcutaneous Drug Delivery Equipment Sales, Revenue and Gross Margin (2020-2025)
6.8.4 Pfizer Subcutaneous Drug Delivery Equipment Product Portfolio
6.8.5 Pfizer Recent Developments/Updates
6.9 Sanofi
6.9.1 Sanofi Company Information
6.9.2 Sanofi Description and Business Overview
6.9.3 Sanofi Subcutaneous Drug Delivery Equipment Sales, Revenue and Gross Margin (2020-2025)
6.9.4 Sanofi Subcutaneous Drug Delivery Equipment Product Portfolio
6.9.5 Sanofi Recent Developments/Updates
6.10 Teva Pharmaceutical
6.10.1 Teva Pharmaceutical Company Information
6.10.2 Teva Pharmaceutical Description and Business Overview
6.10.3 Teva Pharmaceutical Subcutaneous Drug Delivery Equipment Sales, Revenue and Gross Margin (2020-2025)
6.10.4 Teva Pharmaceutical Subcutaneous Drug Delivery Equipment Product Portfolio
6.10.5 Teva Pharmaceutical Recent Developments/Updates
6.11 Zogenix
6.11.1 Zogenix Company Information
6.11.2 Zogenix Description and Business Overview
6.11.3 Zogenix Subcutaneous Drug Delivery Equipment Sales, Revenue and Gross Margin (2020-2025)
6.11.4 Zogenix Subcutaneous Drug Delivery Equipment Product Portfolio
6.11.5 Zogenix Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Subcutaneous Drug Delivery Equipment Industry Chain Analysis
7.2 Subcutaneous Drug Delivery Equipment Raw Material Supply Analysis
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Subcutaneous Drug Delivery Equipment Production Mode & Process Analysis
7.4 Subcutaneous Drug Delivery Equipment Sales and Marketing
7.4.1 Subcutaneous Drug Delivery Equipment Sales Channels
7.4.2 Subcutaneous Drug Delivery Equipment Distributors
7.5 Subcutaneous Drug Delivery Equipment Customer Analysis
8 Subcutaneous Drug Delivery Equipment Market Dynamics
8.1 Subcutaneous Drug Delivery Equipment Industry Trends
8.2 Subcutaneous Drug Delivery Equipment Market Drivers
8.3 Subcutaneous Drug Delivery Equipment Market Challenges
8.4 Subcutaneous Drug Delivery Equipment Market Restraints
9 Research Findings and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
FEATURED COMPANIES
Boehringer Ingelheim
Eli Lily
Galaxo
HMD pharmaceuticals
Merck
Novartis
Novo Nordisk
Pfizer Inc
Sanofi
Teva Pharmaceutical
Zogenix
List of Tables
 Table 1. Global Subcutaneous Drug Delivery Equipment Market Value Comparison by Type (2024 VS 2031) & (US$ Million)
 Table 2. Global Subcutaneous Drug Delivery Equipment Market Value by Application (2024 VS 2031) & (US$ Million)
 Table 3. Global Subcutaneous Drug Delivery Equipment Market Competitive Situation by Manufacturers in 2024
 Table 4. Global Subcutaneous Drug Delivery Equipment Sales (K Units) of Key Manufacturers (2020-2025)
 Table 5. Global Subcutaneous Drug Delivery Equipment Sales Market Share by Manufacturers (2020-2025)
 Table 6. Global Subcutaneous Drug Delivery Equipment Revenue (US$ Million) by Manufacturers (2020-2025)
 Table 7. Global Subcutaneous Drug Delivery Equipment Revenue Share by Manufacturers (2020-2025)
 Table 8. Global Market Subcutaneous Drug Delivery Equipment Average Price (USD/Unit) of Key Manufacturers (2020-2025)
 Table 9. Global Key Players of Subcutaneous Drug Delivery Equipment, Industry Ranking, 2022 VS 2023 VS 2024
 Table 10. Global Key Manufacturers of Subcutaneous Drug Delivery Equipment, Manufacturing Sites & Headquarters
 Table 11. Global Key Manufacturers of Subcutaneous Drug Delivery Equipment, Product Type & Application
 Table 12. Global Key Manufacturers of Subcutaneous Drug Delivery Equipment, Date of Enter into This Industry
 Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
 Table 14. Global Subcutaneous Drug Delivery Equipment by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Subcutaneous Drug Delivery Equipment as of 2024)
 Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
 Table 16. Global Subcutaneous Drug Delivery Equipment Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
 Table 17. Global Subcutaneous Drug Delivery Equipment Sales by Region (2020-2025) & (K Units)
 Table 18. Global Subcutaneous Drug Delivery Equipment Sales Market Share by Region (2020-2025)
 Table 19. Global Subcutaneous Drug Delivery Equipment Sales by Region (2026-2031) & (K Units)
 Table 20. Global Subcutaneous Drug Delivery Equipment Sales Market Share by Region (2026-2031)
 Table 21. Global Subcutaneous Drug Delivery Equipment Revenue by Region (2020-2025) & (US$ Million)
 Table 22. Global Subcutaneous Drug Delivery Equipment Revenue Market Share by Region (2020-2025)
 Table 23. Global Subcutaneous Drug Delivery Equipment Revenue by Region (2026-2031) & (US$ Million)
 Table 24. Global Subcutaneous Drug Delivery Equipment Revenue Market Share by Region (2026-2031)
 Table 25. North America Subcutaneous Drug Delivery Equipment Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 26. North America Subcutaneous Drug Delivery Equipment Sales by Country (2020-2025) & (K Units)
 Table 27. North America Subcutaneous Drug Delivery Equipment Sales by Country (2026-2031) & (K Units)
 Table 28. North America Subcutaneous Drug Delivery Equipment Revenue by Country (2020-2025) & (US$ Million)
 Table 29. North America Subcutaneous Drug Delivery Equipment Revenue by Country (2026-2031) & (US$ Million)
 Table 30. Europe Subcutaneous Drug Delivery Equipment Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 31. Europe Subcutaneous Drug Delivery Equipment Sales by Country (2020-2025) & (K Units)
 Table 32. Europe Subcutaneous Drug Delivery Equipment Sales by Country (2026-2031) & (K Units)
 Table 33. Europe Subcutaneous Drug Delivery Equipment Revenue by Country (2020-2025) & (US$ Million)
 Table 34. Europe Subcutaneous Drug Delivery Equipment Revenue by Country (2026-2031) & (US$ Million)
 Table 35. Asia Pacific Subcutaneous Drug Delivery Equipment Revenue by Region: 2020 VS 2024 VS 2031 (US$ Million)
 Table 36. Asia Pacific Subcutaneous Drug Delivery Equipment Sales by Region (2020-2025) & (K Units)
 Table 37. Asia Pacific Subcutaneous Drug Delivery Equipment Sales by Region (2026-2031) & (K Units)
 Table 38. Asia Pacific Subcutaneous Drug Delivery Equipment Revenue by Region (2020-2025) & (US$ Million)
 Table 39. Asia Pacific Subcutaneous Drug Delivery Equipment Revenue by Region (2026-2031) & (US$ Million)
 Table 40. Latin America Subcutaneous Drug Delivery Equipment Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 41. Latin America Subcutaneous Drug Delivery Equipment Sales by Country (2020-2025) & (K Units)
 Table 42. Latin America Subcutaneous Drug Delivery Equipment Sales by Country (2026-2031) & (K Units)
 Table 43. Latin America Subcutaneous Drug Delivery Equipment Revenue by Country (2020-2025) & (US$ Million)
 Table 44. Latin America Subcutaneous Drug Delivery Equipment Revenue by Country (2026-2031) & (US$ Million)
 Table 45. Middle East and Africa Subcutaneous Drug Delivery Equipment Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 46. Middle East and Africa Subcutaneous Drug Delivery Equipment Sales by Country (2020-2025) & (K Units)
 Table 47. Middle East and Africa Subcutaneous Drug Delivery Equipment Sales by Country (2026-2031) & (K Units)
 Table 48. Middle East and Africa Subcutaneous Drug Delivery Equipment Revenue by Country (2020-2025) & (US$ Million)
 Table 49. Middle East and Africa Subcutaneous Drug Delivery Equipment Revenue by Country (2026-2031) & (US$ Million)
 Table 50. Global Subcutaneous Drug Delivery Equipment Sales (K Units) by Type (2020-2025)
 Table 51. Global Subcutaneous Drug Delivery Equipment Sales (K Units) by Type (2026-2031)
 Table 52. Global Subcutaneous Drug Delivery Equipment Sales Market Share by Type (2020-2025)
 Table 53. Global Subcutaneous Drug Delivery Equipment Sales Market Share by Type (2026-2031)
 Table 54. Global Subcutaneous Drug Delivery Equipment Revenue (US$ Million) by Type (2020-2025)
 Table 55. Global Subcutaneous Drug Delivery Equipment Revenue (US$ Million) by Type (2026-2031)
 Table 56. Global Subcutaneous Drug Delivery Equipment Revenue Market Share by Type (2020-2025)
 Table 57. Global Subcutaneous Drug Delivery Equipment Revenue Market Share by Type (2026-2031)
 Table 58. Global Subcutaneous Drug Delivery Equipment Price (USD/Unit) by Type (2020-2025)
 Table 59. Global Subcutaneous Drug Delivery Equipment Price (USD/Unit) by Type (2026-2031)
 Table 60. Global Subcutaneous Drug Delivery Equipment Sales (K Units) by Application (2020-2025)
 Table 61. Global Subcutaneous Drug Delivery Equipment Sales (K Units) by Application (2026-2031)
 Table 62. Global Subcutaneous Drug Delivery Equipment Sales Market Share by Application (2020-2025)
 Table 63. Global Subcutaneous Drug Delivery Equipment Sales Market Share by Application (2026-2031)
 Table 64. Global Subcutaneous Drug Delivery Equipment Revenue (US$ Million) by Application (2020-2025)
 Table 65. Global Subcutaneous Drug Delivery Equipment Revenue (US$ Million) by Application (2026-2031)
 Table 66. Global Subcutaneous Drug Delivery Equipment Revenue Market Share by Application (2020-2025)
 Table 67. Global Subcutaneous Drug Delivery Equipment Revenue Market Share by Application (2026-2031)
 Table 68. Global Subcutaneous Drug Delivery Equipment Price (USD/Unit) by Application (2020-2025)
 Table 69. Global Subcutaneous Drug Delivery Equipment Price (USD/Unit) by Application (2026-2031)
 Table 70. Boehringer Ingelheim Company Information
 Table 71. Boehringer Ingelheim Description and Business Overview
 Table 72. Boehringer Ingelheim Subcutaneous Drug Delivery Equipment Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
 Table 73. Boehringer Ingelheim Subcutaneous Drug Delivery Equipment Product
 Table 74. Boehringer Ingelheim Recent Developments/Updates
 Table 75. Eli Lily Company Information
 Table 76. Eli Lily Description and Business Overview
 Table 77. Eli Lily Subcutaneous Drug Delivery Equipment Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
 Table 78. Eli Lily Subcutaneous Drug Delivery Equipment Product
 Table 79. Eli Lily Recent Developments/Updates
 Table 80. Galaxo Company Information
 Table 81. Galaxo Description and Business Overview
 Table 82. Galaxo Subcutaneous Drug Delivery Equipment Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
 Table 83. Galaxo Subcutaneous Drug Delivery Equipment Product
 Table 84. Galaxo Recent Developments/Updates
 Table 85. HMD pharmaceuticals Company Information
 Table 86. HMD pharmaceuticals Description and Business Overview
 Table 87. HMD pharmaceuticals Subcutaneous Drug Delivery Equipment Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
 Table 88. HMD pharmaceuticals Subcutaneous Drug Delivery Equipment Product
 Table 89. HMD pharmaceuticals Recent Developments/Updates
 Table 90. Merck Company Information
 Table 91. Merck Description and Business Overview
 Table 92. Merck Subcutaneous Drug Delivery Equipment Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
 Table 93. Merck Subcutaneous Drug Delivery Equipment Product
 Table 94. Merck Recent Developments/Updates
 Table 95. Novartis Company Information
 Table 96. Novartis Description and Business Overview
 Table 97. Novartis Subcutaneous Drug Delivery Equipment Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
 Table 98. Novartis Subcutaneous Drug Delivery Equipment Product
 Table 99. Novartis Recent Developments/Updates
 Table 100. Novo Nordisk Company Information
 Table 101. Novo Nordisk Description and Business Overview
 Table 102. Novo Nordisk Subcutaneous Drug Delivery Equipment Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
 Table 103. Novo Nordisk Subcutaneous Drug Delivery Equipment Product
 Table 104. Novo Nordisk Recent Developments/Updates
 Table 105. Pfizer Company Information
 Table 106. Pfizer Description and Business Overview
 Table 107. Pfizer Subcutaneous Drug Delivery Equipment Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
 Table 108. Pfizer Subcutaneous Drug Delivery Equipment Product
 Table 109. Pfizer Recent Developments/Updates
 Table 110. Sanofi Company Information
 Table 111. Sanofi Description and Business Overview
 Table 112. Sanofi Subcutaneous Drug Delivery Equipment Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
 Table 113. Sanofi Subcutaneous Drug Delivery Equipment Product
 Table 114. Sanofi Recent Developments/Updates
 Table 115. Teva Pharmaceutical Company Information
 Table 116. Teva Pharmaceutical Description and Business Overview
 Table 117. Teva Pharmaceutical Subcutaneous Drug Delivery Equipment Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
 Table 118. Teva Pharmaceutical Subcutaneous Drug Delivery Equipment Product
 Table 119. Teva Pharmaceutical Recent Developments/Updates
 Table 120. Zogenix Company Information
 Table 121. Zogenix Description and Business Overview
 Table 122. Zogenix Subcutaneous Drug Delivery Equipment Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
 Table 123. Zogenix Subcutaneous Drug Delivery Equipment Product
 Table 124. Zogenix Recent Developments/Updates
 Table 125. Key Raw Materials Lists
 Table 126. Raw Materials Key Suppliers Lists
 Table 127. Subcutaneous Drug Delivery Equipment Distributors List
 Table 128. Subcutaneous Drug Delivery Equipment Customers List
 Table 129. Subcutaneous Drug Delivery Equipment Market Trends
 Table 130. Subcutaneous Drug Delivery Equipment Market Drivers
 Table 131. Subcutaneous Drug Delivery Equipment Market Challenges
 Table 132. Subcutaneous Drug Delivery Equipment Market Restraints
 Table 133. Research Programs/Design for This Report
 Table 134. Key Data Information from Secondary Sources
 Table 135. Key Data Information from Primary Sources
 Table 136. Authors List of This Report


List of Figures
 Figure 1. Product Picture of Subcutaneous Drug Delivery Equipment
 Figure 2. Global Subcutaneous Drug Delivery Equipment Market Value Comparison by Type (2020-2031) & (US$ Million)
 Figure 3. Global Subcutaneous Drug Delivery Equipment Market Share by Type: 2024 & 2031
 Figure 4. Syringe Based Subcutaneous Drug Delivery Product Picture
 Figure 5. Subcutaneous Implants Product Picture
 Figure 6. Pen Systems for Subcutaneous Drug Delivery Product Picture
 Figure 7. Auto Injectors Product Picture
 Figure 8. Pump Based Drug Delivery Systems Product Picture
 Figure 9. Global Subcutaneous Drug Delivery Equipment Market Value by Application (2020-2031) & (US$ Million)
 Figure 10. Global Subcutaneous Drug Delivery Equipment Market Share by Application: 2024 & 2031
 Figure 11. In-Patient
 Figure 12. Out-Patient
 Figure 13. Clinic
 Figure 14. Others
 Figure 15. Global Subcutaneous Drug Delivery Equipment Revenue, (US$ Million), 2020 VS 2024 VS 2031
 Figure 16. Global Subcutaneous Drug Delivery Equipment Market Size (2020-2031) & (US$ Million)
 Figure 17. Global Subcutaneous Drug Delivery Equipment Sales (2020-2031) & (K Units)
 Figure 18. Global Subcutaneous Drug Delivery Equipment Average Price (USD/Unit) & (2020-2031)
 Figure 19. Subcutaneous Drug Delivery Equipment Report Years Considered
 Figure 20. Subcutaneous Drug Delivery Equipment Sales Share by Manufacturers in 2024
 Figure 21. Global Subcutaneous Drug Delivery Equipment Revenue Share by Manufacturers in 2024
 Figure 22. Global 5 and 10 Largest Subcutaneous Drug Delivery Equipment Players: Market Share by Revenue in Subcutaneous Drug Delivery Equipment in 2024
 Figure 23. Subcutaneous Drug Delivery Equipment Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024
 Figure 24. Global Subcutaneous Drug Delivery Equipment Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
 Figure 25. North America Subcutaneous Drug Delivery Equipment Sales Market Share by Country (2020-2031)
 Figure 26. North America Subcutaneous Drug Delivery Equipment Revenue Market Share by Country (2020-2031)
 Figure 27. U.S. Subcutaneous Drug Delivery Equipment Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 28. Canada Subcutaneous Drug Delivery Equipment Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 29. Europe Subcutaneous Drug Delivery Equipment Sales Market Share by Country (2020-2031)
 Figure 30. Europe Subcutaneous Drug Delivery Equipment Revenue Market Share by Country (2020-2031)
 Figure 31. Germany Subcutaneous Drug Delivery Equipment Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 32. France Subcutaneous Drug Delivery Equipment Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 33. U.K. Subcutaneous Drug Delivery Equipment Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 34. Italy Subcutaneous Drug Delivery Equipment Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 35. Russia Subcutaneous Drug Delivery Equipment Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 36. Asia Pacific Subcutaneous Drug Delivery Equipment Sales Market Share by Region (2020-2031)
 Figure 37. Asia Pacific Subcutaneous Drug Delivery Equipment Revenue Market Share by Region (2020-2031)
 Figure 38. China Subcutaneous Drug Delivery Equipment Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 39. Japan Subcutaneous Drug Delivery Equipment Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 40. South Korea Subcutaneous Drug Delivery Equipment Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 41. India Subcutaneous Drug Delivery Equipment Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 42. Australia Subcutaneous Drug Delivery Equipment Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 43. Taiwan Subcutaneous Drug Delivery Equipment Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 44. Indonesia Subcutaneous Drug Delivery Equipment Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 45. Thailand Subcutaneous Drug Delivery Equipment Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 46. Malaysia Subcutaneous Drug Delivery Equipment Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 47. Philippines Subcutaneous Drug Delivery Equipment Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 48. Latin America Subcutaneous Drug Delivery Equipment Sales Market Share by Country (2020-2031)
 Figure 49. Latin America Subcutaneous Drug Delivery Equipment Revenue Market Share by Country (2020-2031)
 Figure 50. Mexico Subcutaneous Drug Delivery Equipment Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 51. Brazil Subcutaneous Drug Delivery Equipment Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 52. Argentina Subcutaneous Drug Delivery Equipment Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 53. Middle East and Africa Subcutaneous Drug Delivery Equipment Sales Market Share by Country (2020-2031)
 Figure 54. Middle East and Africa Subcutaneous Drug Delivery Equipment Revenue Market Share by Country (2020-2031)
 Figure 55. Turkey Subcutaneous Drug Delivery Equipment Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 56. Saudi Arabia Subcutaneous Drug Delivery Equipment Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 57. UAE Subcutaneous Drug Delivery Equipment Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 58. Global Sales Market Share of Subcutaneous Drug Delivery Equipment by Type (2020-2031)
 Figure 59. Global Revenue Market Share of Subcutaneous Drug Delivery Equipment by Type (2020-2031)
 Figure 60. Global Subcutaneous Drug Delivery Equipment Price (USD/Unit) by Type (2020-2031)
 Figure 61. Global Sales Market Share of Subcutaneous Drug Delivery Equipment by Application (2020-2031)
 Figure 62. Global Revenue Market Share of Subcutaneous Drug Delivery Equipment by Application (2020-2031)
 Figure 63. Global Subcutaneous Drug Delivery Equipment Price (USD/Unit) by Application (2020-2031)
 Figure 64. Subcutaneous Drug Delivery Equipment Value Chain
 Figure 65. Channels of Distribution (Direct Vs Distribution)
 Figure 66. Bottom-up and Top-down Approaches for This Report
 Figure 67. Data Triangulation
 Figure 68. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$2900

This license allows only one user to access the PDF.
Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)
INQUIRE FOR DISCOUNT

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

Leap India

SIMILAR REPORTS

Global Subcutaneous Drug Delivery Devices Market Insights Forecast to 2030
Global On body Drug Delivery Devices Market Research Report 2025
Global Intramuscular Drug Delivery Equipment Market Research Report 2025
Global Subcutaneous Medicine Delivery Devices Market Research Report 2024
Global Medical Supply Delivery Service Market Research Report 2024
Global Potential Therapy Equipment Market Insights Forecast to 2030
Global Dermatology Medical Equipment Market Research Report 2025
Global Skin Medical Beauty Equipment Market Research Report 2024
Global Subcutaneous Injector Market Research Report 2025
On Body Drug Delivery System Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Medical Distribution Market Research Report 2025
Global Vascular Interventional Apparatus Market Insights Forecast to 2030
Global Medical Equipment Outsourcing Market Research Report 2025
Global Interventional Cardiovascular Device Market Research Report 2025
Global Medical Equipment Part Market Research Report 2024
Drug Screening Equipment Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Home Use Medical Equipment Market Insights Forecast to 2030
Global Dermatology Therapeutics Devices Market Research Report 2024
Global Household Medical Equipment Market Insights Forecast to 2030
Global Medical Device and Equipment Certification Market Research Report 2025

RELATED REPORTS

Global Pharma and Healthcare Social Media Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-14Y6812
Fri Sep 12 00:00:00 UTC 2025

Add to Cart

Global Food Additives Testing Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-34O3983
Fri Sep 12 00:00:00 UTC 2025

Add to Cart

Global Gabapentin API Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-9V17601
Fri Sep 12 00:00:00 UTC 2025

Add to Cart

Global Electronic Informed Consent Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-22C17047
Fri Sep 12 00:00:00 UTC 2025

Add to Cart

Call
Buy Now
REQUEST FREE SAMPLE REPORT
Support Contacts
U.S. (TOLL FREE)
+1 (425) 388-2538
THE COMPANY
OUR PRODUCTS
CUSTOMER SUPPORT
POLICES
THE COMPANY
CUSTOMER SUPPORT
OUR PRODUCTS
POLICES
Copyright © 2018 Valuates.com. All Rights Reserved.
Sitemap - Privacy Policy - Terms & Conditions